Protocol to Obtain Blood Samples for Leukemia Research

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767 ·Status: COMPLETED

Biology Studies of Hematologic Cancers

NCT00923442 ·Status: ENROLLING_BY_INVITATION

Collection of Tissue Samples for Cancer Research

NCT00900198 ·Status: RECRUITING

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368 ·Status: COMPLETED

The Expression of Antigens in Bone Marrow Samples From Volunteering Donors.

NCT00706199 ·Status: COMPLETED

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 ·Status: RECRUITING

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

NCT02474160 ·Status: RECRUITING

Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia

NCT01139333 ·Status: COMPLETED

Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth

NCT01174615 ·Status: WITHDRAWN

Collecting and Storing Blood Samples From Patients With Cancer

NCT00900120 ·Status: WITHDRAWN

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

NCT00919425 ·Status: COMPLETED

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 ·Status: RECRUITING

Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients

NCT02553304 ·Status: COMPLETED

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

NCT01653613 ·Status: UNKNOWN

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

NCT01015963 ·Status: COMPLETED

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

NCT00026663 ·Status: COMPLETED

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

NCT03050398 ·Status: TERMINATED ·Phase: PHASE3

Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)

NCT02071056 ·Status: COMPLETED

The Leukemia and Lymphoma Society (LLS) National Research Registry

NCT04806295 ·Status: RECRUITING

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

NCT00580203 ·Status: COMPLETED

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT01441089 ·Status: RECRUITING

CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01

NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA

Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia

NCT01139307 ·Status: COMPLETED

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643 ·Status: RECRUITING

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia

NCT01016379 ·Status: COMPLETED